Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: A replication study in a Taiwanese cohort

Parkinsonism and Related Disorders

Volumn 19, Issue 2, 2013, Pages 251-255

  Wu Chou, Yah Huei ^a   Chen, Ying Ting ^b   Yeh, Tu Hsueh ^a   Chang, Hsiu Chen ^a   Weng, Yi Hsin ^a   Lai, Szu Chia ^a   Huang, Chia Ling ^c   Chen, Rou Shayn ^a   Huang, Ying Zu ^a   Chen, Chiung Chu ^a   Hung, June ^a   Chuang, Wen Li ^a   Lin, Wey Yil ^a   Chen, Chien Hsiun ^b   Lu, Chin Song ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c SAINT PAUL S HOSPITAL   (Taiwan)

Author keywords

Genetic susceptibility; LRRK2; Parkinson's disease; Replication study; SNCA

Indexed keywords

ALPHA SYNUCLEIN; LEUCINE RICH REPEAT KINASE 2;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; ALPHA SYNUCLEIN GENE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LEUCINE RICH REPEAT KINASE 2 GENE; MAJOR CLINICAL STUDY; PARKINSON DISEASE; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; REPLICATION STUDY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWANESE;

AGED; ALPHA-SYNUCLEIN; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; TAIWAN;

EID: 84873719976     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.10.019     Document Type: Article

References (30)

1. Farrer M.J. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 2006, 7:306-318.
2. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., Goedert M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 1998, 1998(95):6469-6473.
3. Dachsel J.C., Farrer M.J. LRRK2 and Parkinson disease. Arch Neurol 2010, 67(5):542-547.
4. Schapira A.H. The importance of LRRK2 mutations in Parkinson's disease. Arch Neurol 2006, 63:1225-1228.
5. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., et al. Mutations in LRRK2 cause autosomal dominant Parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.
6. Lesage S., Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 2009, 18(R1):R48-R59.
7. Lesage S., Brice A. Role of Mendelian genes in " sporadic" Parkinson's disease. Parkinsonism Relat Disord 2012, 18(Suppl. 1):S66-S70.
8. Johnson G.C., Esposito L., Barratt B.J., Smith A.N., Heward J., Di Genova G., et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001, 29:233-237.
9. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999, 56:33-39.
10. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B. The structure of haplotype blocks in the human genome. Science 2003, 296:2225-2229.
11. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
12. Farrer M., Maraganore D.M., Lockhart P., Singleton A., Lesnick T.G., de Andrade M., et al. Alpha-synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet 2001, 10:1847-1851.
13. Pals P., Lincoln S., Manning J., Heckman M., Skipper L., Hulihan M., et al. alpha-Synuclein promoter confers susceptibility to Parkinson's disease. Ann Neurol 2004, 56(4):591-595.
14. Maraganore D.M., de Andrade M., Elbaz A., Farrer M.J., Ioannidis J.P., Krüger R., et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 2006, 296:661-670.
15. Mueller J.C., Fuchs J., Hofer A., Zimprich A., Lichtner P., Illig T., et al. Multiple regions of alpha-synuclein are associated with Parkinson's disease. Ann Neurol 2005, 57:535-541.
16. Mizuta I., Satake W., Nakabayashi Y., Ito C., Suzuki S., Momose Y., et al. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Hum Mol Genet 2006, 15:1151-1158.
17. Winkler S., Hagenah J., Lincoln S., Heckman M., Haugarvoll K., Lohmann-Hedrich K., et al. alpha-Synuclein and Parkinson disease susceptibility. Neurology 2007, 69(18):1745-1750.
18. Ross O.A., Gosal D., Stone J.T., Lincoln S.J., Heckman M.G., Irvine G.B., et al. Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease. Mech Ageing Dev 2007, 128:378-382.
19. Myhre R., Toft M., Kachergus J., Hulihan M.M., Aasly J.O., Klungland H., et al. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population. Acta Neurol Scand 2008, 118(5):320-327.
20. Mata I.F., Shi M., Agarwal P., Chung K.A., Edwards K.L., Factor S.A., et al. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Arch Neurol 2010, 67:1350-1536.
21. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009, 41:1303-1307.
22. Simon-Sanchez J., Schulte C., Bras J.M., Sharma M., Gibbs J.R., Berg D., et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009, 41:1308-1312.
23. Di Fonzo A., Wu-Chou Y.H., Lu C.S., van Doeselaar M., Simons E.J., Rohé C.F., et al. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics 2006, 7(3):133-138.
24. Farrer M.J., Stone J.T., Lin C.H., Dächsel J.C., Hulihan M.M., Haugarvoll K., et al. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat Disord 2007, 13(2):89-92.
25. Tan E.K., Zhao Y., Skipper L., Tan M.G., Di Fonzo A., Sun L., et al. The LRRK2 Gly2385R variant is associated with risk of Parkinson's disease: genetic and functional evidence. Hum Genet 2007, 120:857-863.
26. Lu C.S., Wu-Chou Y.H., van Doeselaar M., Simons E.J., Chang H.C., Breedveld G.J., et al. The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population. Neurogenetics 2008, 9(4):271-276.
27. Ross O.A., Wu Y.R., Lee M.C., Funayama M., Chen M.L., Soto A.I., et al. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Ann Neurol 2008, 64(1):88-92.
28. Tan E.K., Tan L.C., Lim H.Q., Li R., Tang M., Yih Y., et al. LRRK2 R1628P increases risk of Parkinson's disease: replication evidence. Hum Genet 2008, 124(3):287-288.
29. Tan E.K., Peng R., Teo Y.Y., Tan L.C., Angeles D., Ho P., et al. Multiple LRRK2 variants modulate risk of Parkinson disease: A Chinese multicenter study. Hum Mutat 2010, 31(5):561-568.
30. Ross O.A., Soto-Ortolaza A.I., Heckman M.G., Aasly J.O., Abahuni N., Annesi G., et al. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol 2011, 10(10):898-908.